Prevalence and severity of wheezing in the first year of life in the city of Santo André, Brazil* *Study conducted at Faculdade de Medicina do ABC, Santo André, SP, Brazil.

Ferreira, Isabel Cristina Carqueijeiro; Wandalsen, Neusa Falbo

doi:10.1016/s2359-3482(15)30005-1

Cited by 2 publications

(3 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…4 Consistently, worldwide epidemiologic studies reported that 48.5% children had at least 1 episode of wheezing and breathlessness before 1 year of age, and that 30% of the preschool-age children who have wheezing episodes will develop asthma in the future. 5 The prevalence of wheezing among 6–7 year old children ranged from 2.4% in Jodhpur (India) to 37.6% in Costa Rica. 3 In addition, it has been reported that 80% of asthmatic children experienced wheezing episodes at age of 6 years or younger, and 50% of them had wheezing episodes when they were younger than 3 years.…”

Section: Introductionmentioning

confidence: 99%

Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children

Zhou¹,

Lu²,

Zhu³

et al. 2018

PPA

View full text Add to dashboard Cite

ObjectiveTo explore the effect of a smart nebulizing device on the rate of adherence to inhaled corticosteroid (ICS) in children with positive Asthma Predictive Index.MethodsIn total, 65 children with positive Asthma Predictive Index and under the age of 5 years who visited our hospital from October 2015 through October 2016, were randomly assigned to receive conventional nebulization or smart nebulization. The smart nebulizer was connected to smart phones via an App. The following information was collected: rate of adherence to ICS, frequency of emergency visits or hospitalizations, application of antibiotics or oral steroids, and wheezing progression or improvement.ResultsThe rate of adherence to ICS was 86.67% (26/30), 76.67% (23/30), and 67.33% (20/30) in the smart nebulization group, and 62.86% (22/35), 51.42% (18/35), and 40.00% (14/35) in the conventional nebulization group after 4-, 8-, and 12-week therapy, respectively. There were significant differences between the 2 groups at all of the time points (P<0.05). Both day- and night-time wheezing scores were significantly lower in the smart nebulization group than those of the conventional nebulization group after 4-, 8-, and 12-week therapy (P<0.05). The frequency of emergency visits, comorbidity of respiratory infection, antibiotics or systemic steroid usage, and therapeutic cost for additional treatment during the 12-week study period, was significantly lower in the smart nebulization group than that in the conventional nebulization group (P<0.05).ConclusionA smart electronic nebulization device could significantly improve the rate of adherence to ICS in children under the age of 5 years, and thus could significantly reduce the frequency of emergency visits and respiratory infections as well as the usage of antibiotics or systemic steroids.

show abstract

Section: Introductionmentioning

confidence: 99%

Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children

Zhou¹,

Lu²,

Zhu³

et al. 2018

PPA

View full text Add to dashboard Cite

show abstract

“…A literatura mostra que há fatores de risco associados à sibilância recorrente. Houve associação entre sibilância recorrente e a falta do aleitamento materno, neste trabalho, como em outros estudos com o questionário EISL 38,108,110,111 . Um estudo francês com prematuros, não encontrou associação entre aleitamento materno e sibilância recorrente 107 .…”

Section: Sibilância Recorrenteunclassified

“…O convívio com animais não é significante para sibilância recorrente neste trabalho, semelhante aos achados de outros estudos com questionário EISL 106,108,109,113,125 . Porém, já foi publicada a associação entre convívio com animais e sibilância recorrente 36,38 .…”

Section: Sibilância Recorrenteunclassified

Prevalência e fatores de risco para sibilância recorrente em crianças com alto risco de infecção respiratória viral aguda grave

Simões¹

View full text Add to dashboard Cite

Introduction:The recurrent wheezing (RW) has a high prevalence in the early years of life. In this age group, there is a relationship between the occurrence of severe Respiratory Syncytial Virus (RSV) infection and evolution with subsequent RW, according to epidemiological studies. Some groups of children such as preterm infants with and without bronchopulmonary dysplasia and children with congenital heart disease with hemodynamic consequences are at high risk of developing severe RSV infection. This, in turn, leads to anatomical, functional and immunological lasting changes that can be related to RW.Objective: This study will evaluate the overall prevalence and the risk factors associated to RW development in infants with high risk of having severe RSV infections. Between risk factors, analyze the use of passive immunization with Palivizumabe modified the prevalence of RW. Methods: Cross sectional study conducted between June 2014 and August 2015, in reference center. The patients selected receiving Palivizumabe in 2012, born between 2010 and 2012 and preterm that did not receive passive immunization by not attending the using criterion, birth in 2011 and 2012. The evaluation was the guided questionnaire in telephone interview. Results:The 512 children analyzed with mean age 39.3 ± 5.64 months and median 39 months (18 -54). In the first group, 261 children with mean gestational age 31.2 ± 4.94 weeks and median 29 weeks (24 -41) who received Palivizumab. In the second group, 251 preterm children with mean gestational age 34.0 ± 1.79 weeks and median 34 weeks (28 -36) who did not receiving passive immunization (p<0.001).The prevalence of RW among 512 children was 25.8% (95% CI: 22.1 -29.7). In the group receiving with Palivizumab, the prevalence was 30.7% (95% CI: 25.3 -36.5) and in the group without prophylaxis, it was 20.7% (95%CI: 16.0 -26.1). These results show a statistically significant difference (p = 0.010). Risk factors associated 10 with recurrent wheezing, by univariate analysis, were birth weight less than 1500g, gestational age below 32 weeks, lack of breastfeeding, hospitalization for wheezing in the first years of life, living with more than three children in the same household, food allergy and atopic dermatitis in children, food allergies and asthma in the parents. With multivariate analysis, associated factors were gestational age between

show abstract

Prevalence and severity of wheezing in the first year of life in the city of Santo André, Brazil* *Study conducted at Faculdade de Medicina do ABC, Santo André, SP, Brazil.

Cited by 2 publications

References 27 publications

Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children

Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children

Prevalência e fatores de risco para sibilância recorrente em crianças com alto risco de infecção respiratória viral aguda grave

Contact Info

Product

Resources

About